Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

It is with pride and gratitude that we reflect on the remarkable 10-year journey of European Journal of Arrhythmia & Electrophysiology. With the vital contributions of all of our esteemed authors, reviewers and editorial board members, the journal has served as a platform for groundbreaking research, clinical insights and news that have helped shape the […]

Marked prolongation of QRS duration after initiation of dronedarone therapy

Conrad Genz, Hans D. Esperer, Alexander Schmeisser, Ruediger C. Braun-Dullaeus, Samir M. Said
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Aug 10th 2018 Heart International 2014;9(1):33-35 DOI: https://doi.org/10.5301/HEART.2014.12491
Select a Section…
1

Abstract

Overview

Dronedarone is a relatively new antiarrhythmic drug and is held to be less proarrhythmic than comparable compounds,
although its proarrhythmia potential in humans has not been sufficiently evaluated. We describe a so far
unreported dronedarone effect, namely a significant alteration of both the morphology and the duration of the
QRS complex on the electro cardiogram in a 41-year old patient with symptomatic paroxysmal atrial fibrillation.

Keywords

Adverse drug events, Antiarrhythmic drugs, Atrial fibrillation, Dronedarone.

2

Article Information

Correspondence

Samir M. Said, Otto-von-Guericke University University Hospital, Centre of Internal Medicine Division of Cardiology Leipziger Str. 44 39120 Magdeburg, Germany samir.said@med.ovgu.de

3

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup